National Health (Price and Special Patient Contribution) Amendment Determination 2018 (No. 9) (PB 106 of 2018) (Cth)

PB 106 of 2018

National Health (Price and Special Patient Contribution) Amendment Determination 2018 (No. 9)

National Health Act 1953

___________________________________________________________________________

I, SEAN LANE, Acting Assistant Secretary, Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health, make this Determination under section 85B of the National Health Act 1953.

Dated      28 November 2018

SEAN LANE

Acting Assistant Secretary

Pricing and PBS Policy Branch

Technology Assessment and Access Division

Department of Health

_________________________________________________________________________

1. Name of Instrument

(1)This Instrument is the National Health (Price and Special Patient Contribution) Amendment Determination 2018 (No. 9).

(2)This Instrument may also be cited as PB 106 of 2018.

1. Commencement

This Instrument commences on 1 December 2018.

1. Amendment of National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010)

Schedule 1 amends the National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010).

Schedule 1     Amendments

1. Schedule 1, entry for Clonazepam

omit:

Tablet 2 mg	Oral	Rivotril	100	9.96	12.10
Tablet 500 mcg	Oral	Rivotril	100	5.29	7.00

substitute:

Tablet 2 mg	Oral	Rivotril	100	9.96	12.10
Tablet 500 mcg	Oral	Rivotril	50	2.65	3.51
100	7.01

1. Schedule 1, entry for Dorzolamide with timolol

omit from the column headed “Claimed Price”:   10.61      substitute:                10.78

1. Schedule 1, entry for Hypromellose with Carbomer 980

omit from the column headed “Claimed Price”:   7.15        substitute:                7.58

1. Schedule 1, entry for Hypromellose with Dextran

omit from the column headed “Claimed Price”:   6.69        substitute:                7.01

1. Schedule 1, entry for Meloxicam in the form Capsule 7.5 mg

omit from the column headed “Claimed Price”:   4.93        substitute:                5.39

1. Schedule 1, entry for Meloxicam in the form Capsule 15 mg

omit from the column headed “Claimed Price”:   6.13        substitute:                6.59

1. Schedule 1, entry for Meloxicam in the form Tablet 7.5 mg

omit from the column headed “Claimed Price”:   4.93        substitute:                5.39

1. Schedule 1, entry for Meloxicam in the form Tablet 15 mg

omit from the column headed “Claimed Price”:   6.13        substitute:                6.59